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Summary 
In mature B ceils, signals transduced through membrane immunoglobulin (Ig) produce cellular 
activation, yet the same receptor can also mediate deletion and silencing ofautoreactive B ceils. 
In addition, Ig expression during the antigen-independent phase of B cell development regu- 
lates  the precursor B  (pre-B) ceil transition and allelic  exclusion. To account for the diverse 
regulatory functions induced by membrane Ig,  it has been proposed that individual receptor 
components have independent physiologic activities. Here we establish  a role for Igcx in the 
pre-B cell transition and allelic exclusion. We find that the cytoplasmic domain oflg~ contains 
sufficient information to trigger both of these antigen-independent events. Direct comparisons 
of the cytoplasmic domains of Igor and lg[3 show that the two are indistinguishable in the in- 
duction of the pre-B cell transition and ailelic exclusion. Our experiments suggest that, despite 
the reported differences in certain biochemical assays, Ig0t and Ig[3 have redundant functions in 
the developing B cell. 
L 
Ymphocyte development progresses through a series of 
ordered events,  ultimately resulting in  B  and  T  cells 
that  express clonotypic Ig or TC1Ks. Although  the  initial 
lineage  commitment  events  are  independent  of Ig  and 
TCR  expression, many of the subsequent checkpoints in 
both the T  and B  cell pathways are regulated by these re- 
ceptors. In the bone marrow, regulation of the B cell path- 
way  by  membrane  Ig  begins  in  the  earliest  identifiable 
committed B  cell progenitors (pro-B ceils)? Experiments 
with  transgenic  and  gene-targeted mice have shown  that 
progression from the pro-B ceil to precursor B (pre-B) ceil 
stage  is dependent on expression of the membrane-bound 
form of heavy chain (1-3). In the pre-B ceil,  be expression 
regulates a second checkpoint, the allelic exclusion of a sec- 
ond heavy chain locus (4-6). Both the pre-B cell transition 
and allelic  exclusion are believed to  be  antigen-indepen- 
dent events since they can occur before Ig light chain gene 
rearrangements, and thus before the assembly of a mature 
receptor Ig. 
After light chain gene rearrangement and completion of 
cell surface receptor assembly, interactions between surface 
Ig and antigen largely control cell fate. Binding of self-anti- 
gens to the receptor in the newly matured B  ceil can lead 
1Abbreviations used in this paper: pre--B cell, precursor  B cell; pro-B cell, B 
cell progenitor; RAG, recombinase-activating  gene. 
to receptor editing (7, 8) and deletion of autoreactive cells 
(9-12). By contrast, binding of antigens to the Ig receptor 
in mature B  cells is one of the key elements in activating 
clonal expansion and antibody secretion. Thus, a single  re- 
ceptor has a number of apparently distinct antigen-depen- 
dent and -independent regulatory functions in  the B  cell 
pathway. 
Two models have been put forward to account for these 
distinct activities: Either one receptor produces several quali- 
tatively different signals, or, alternatively, similar signals are 
interpreted differently in  different cellular contexts.  Sup- 
port for the first  idea, that the signals  are different, comes 
from structural and biochemical studies of the Ig receptor. 
The mature  receptor is  associated  through  its  transmem- 
brane domain with  the  two signaling molecules, Igo~ and 
Ig13, that form a disulfide-linked heterodimer (13).  When 
tested in isolation, both can activate mature B cells, but the 
two proteins bind to different sets of cellular kinases  (14), 
and several groups have found that the responses activated 
by Igci and Ig[3 in transfected cell lines are different (15-18). 
We have recently shown that the cytoplasmic domain of 
Ig[3 can activate the pre-B transition and allelic  exclusion 
in vivo by a mechanism that requires tyrosine phosphoryla- 
tion (19). Here we examine whether Igc~ can mediate these 
antigen-independent events, and whether lgoL and Ig[3 have 
different physiologic functions during early B cell develop- 
ment. 
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Constructs and Mice.  Many of  the heavy chain vectors used for 
these  experiments  have been  described  elsewhere  (19).  Briefly, 
the starting construct for the heavy chain transgenes was a HindlII- 
BamHl fragment of the human ~  gene, containing the constant 
and membrane exons, and modified to direct the synthesis of  only 
the membrane form of  human Ix (20). To this fragment we added 
a  HindlII-EcoRI piece  containing a  murine  V  region  (9)  and 
murine  enhancer  (21).  Finally,  unique  BamHI  and  NotI  sites 
were placed around the membrane exons for rapid replacement 
of the wild-type sequence with specifically modified transmem- 
brane domains (15) (Fig. 1 A). In addition to the wild-type heavy 
chain construct, we have created four others.  The first construct, 
which we call YS :VV-IgM, differs from the  wild-type in that 
Tyr-587  and  Ser-588  of the  wild-type transmembrane  domain 
are replaced by Val.  This mutation renders the molecule unable 
to contact endogenous Ig~ and Ig[3 (15). The Ig~ and Ig~ cyto- 
plasmic tails were amplified  from plasmids by PCtL, and, after se- 
quence verification,  they were subcloned in frame at the end of 
the heavy chain transmembrane domain (15). The addition of the 
cytoplasmic tail of Ig{3 to the YS:VV Ix mutant gave rise to the 
YS : VV-IgM : IgJ3 chimeric  molecule  (15).  Similarly,  YS: W- 
IgM:Ig~ was created by adding the cytoplasmic tail of Ig~ onto 
the YS: VVIx. Finally, the YS : VV-IgM : Igl3 Y: F chimera differs 
from YS:W-IgM:Ig~3 in the Tyr-195 and Tyr-206 in the cyto- 
plasmic  domain of Igl3 have been replaced with Phe  (15).  The 
light chain constructs are composed of a HindlII fragment of the 
mouse V region (9) added to a HindlII-BamHI piece containing 
the mouse light chain constant region (22). (Fig. 1 B) Expression 
of this  heavy and hght chain pair in vivo results in an antibody 
that reacts specifically with H2  k/k but not with H2  d/d (9). To cre- 
ate  transgenic  mice,  equimolar amounts of purified DNA from 
heavy and light chain constructs was coinjected into recombina- 
tion-activating gene  (RAG)I-/-H2d/ax CD2F1  H2  a/d fertilized 
oocytes (23). Two independent integrants  were obtained for each 
hne. The founders were then back-crossed to either RAG-1 -/- 
H2  d/a (2, 24) or BALB/c mice. 
Intracellular Human IgM Expression.  The presence of human 
heavy chain in the cytoplasm of  B cells was verified by FACS  |  B 
cells  from  the  bone  marrow  of 6-8-wk-old  mice  were  first 
stained with PE-B220 (PharMingen, San Diego, CA) and FITC- 
CD43 ($7 hybridoma; American Type Culture Collection, Rock- 
ville, MD)  antibodies  for 30 rain.  The cells were then fixed  by 
adding to them a solution of 4% paraformaldehyde in PBS for 10 
Figure 1.  Diagrammatic  representation of the mouse-human hybrid 
and the mouse g light chain tramgenes. (A) Heavy chain gene. (B) Light 
chain gene. Together, the heavy and light chain genes produce an Ig that 
reacts with the 54.1 antiidiotypic antibody. VDJ and VJ, variable region 
coding exom; e, mouse heavy chain enhancer; CH1-CH4, human con- 
stant region coding exom; M1 and M2, transmembrane domain coding 
exons; CL, constant region coding exons for the mouse light chain. 
min.  After one  wash in PBS/1%  FCS  solution,  the  fixed  cells 
were permeabilized with 1% saponin for 30 min and stained with 
either anti-human IgM (Southern Biotechnology Associates, Bir- 
mingham, AL), anti-mouse K light chain (PharMingen),  or anti- 
idiotypic antibody (hybridoma 54.1  [9] provided by Dr. D. Nem- 
azee,  National Jewish  Center for Immunology and Respiratory 
Medicine, Denver, CO). Data acquisition  was performed with a 
FACScan  |  (Becton Dickinson & Co., Mountain View, CA), and 
appropriate gating and analysis was done with CellQuest software 
(Becton Dickinson & Co.). 
Flow Cytometric  Analysis.  The following antibodies  were used 
for surface staining  of B cells: PE-B220; FITC-CD43 ($7 hybri- 
doma);  biotin-labeled  anti-human  lgM  (heavy  chain-specific 
DA4.4 clone; Southern Biotechnology Associates); biotin-labeled 
anti-mouse K light chain (Pharmingen); and biotin-labeled anti- 
idiotypic  antibody  (hybridoma 54.1  [9]).  Streptavidin-RED670 
was  the  secondary reagent  (GIBCO  BILL,  Gaithersburg,  MD) 
where biotinylated antibodies  were used. Data were collected on 
a FACSorter  |  and were analyzed using CellQuest software. 
VDJ Recombination and  Allelic Exdusion.  Ig gene  rearrange- 
ments in transgenic  mice were assayed by PCR as previously de- 
scribed  (25). Recombined sequences  of VJ558L  family or D  re- 
gion segments with J segments were amplified from bone marrow 
DNA from two mice for each integrant.  Amplification of inter- 
vening sequences  was used as DNA loading control. Primer se- 
quences and PCR conditions were as previously described  (25). 
Amplified DNA was  visualized  by Southern  hybridization with 
an EcolLI DNA fragment that spans the mouse J  region. In this 
assay, the capability  of a transgene  to inhibit V to DJ recombina- 
tion is evident as an absence of recombined VJ558L sequences. 
Results 
Expression of Transgenic Igs.  To  compare  the  signaling 
functions of Ig~ and Igl3 in vivo, we started with Ig heavy 
chains  that  carried  mutations  in  their  transmembrane  do- 
mains  (YS :VV-IgM),  which  have  been  shown  to  render 
the heavy chain unable to interact with Ig~-Ig[3 (15). The 
cytoplasmic  domains  of Iga  and  Ig[3  were  added  to  the 
YS :VV-IgM to produce the  chimeric molecules YS :W- 
IgM :Ig~ and YS :VV-IgM :Ig~3. These mutant heavy chains 
were combined with  cognate light  chain genes and intro- 
duced into the RAG-1 -/- H2  d/a background, where B cell 
development is blocked at the pro-B cell stage (2,  24, 26). 
An additional modification carried by all of the heavy chain 
genes described below was the deletion of the first poly-A 
addition site, resulting in a gene that directs the synthesis of 
only the membrane form of Ig (4,  20).  Strains  that carried 
the wild-type version of the membrane-only Ig transgenes 
were used as controls. Heavy and light chain gene expres- 
sion was assayed by staining bone marrow cells with a panel 
of mAbs (Fig. 2). The levels of intracellular heavy and hght 
chain expression  (Fig.  2, top and center) and cell surface id- 
iotype  expression  were  similar  in  all  10  of the  transgenic 
strains  tested  in  both  RAG-1 -/-  and  wild-type  back- 
grounds  (Fig.  2,  bottom, and  data  not  shown).  Thus,  all 
transgenic strains produced similar amounts oftransgenic Ig 
and expressed  the receptor on the surface of developing B 
cells. 
Ig~ Induces the Pre-B  Cell  Transition.  Induction of the 
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Figure 2.  Expression of the heavy and light chain transgenes. (Top) Inwacellular  expression of the human Is. heavy chain. Cells, stained with PE-labeled 
anti-B220, were fixed, permeabilized, and stained with biotin-labeled anti-human IgM. Gating was on B220  ~sh cells. (Center) Intracellular expression of 
the mouse K light chain. Cells were treated as in A but were stained with biotin-labeled anti-mouse K chain instead of Iz. Gating was on B220~ cells. 
(Bottom) Surface expression of the fully assembled lgM receptor on B cells  from the bone marrow of ILAG-1-/--transgenic  mice. Bone marrow cells 
were stained with PE-labeled anti-B220, FITC-labeled anti-CD43, and biotin-labeled antiidiotypic antibody 54.1 (9). Gating was on CD43+B220  high 
cells. The numbers in each quadrant represent percentages of gated lymphocytes. 
pro-  to  pre-B  cell  transition  was  assessed by  staining of 
bone marrow cells with anti-B220 and anti-CD43 antibod- 
ies (Fig. 3).  Pro-B cells are B220+CD43 +, whereas more 
mature cells lose expression of CD43 and therefore become 
B220+CD43 -.  Mice  that  carry  complete  YS:VV  mem- 
brane Igs, in contrast to transgenic mice that carry the wild- 
type membrane  Ig, were  unable to induce the pre-B  cell 
transition (Fig. 3).  Thus,  even in the presence of the light 
chain, the mutant Igs were inactive, suggesting that contact 
with Igor and Ig{3 was the essential factor in the induction 
of the pre--B cell transition, irrespective of light chain ex- 
pression and antigen receptor assembly. 
We have shown that the cytoplasmic domain of Igl3 was 
sufficient  to  activate  the  pre--B  cell  transition  when  ex- 
pressed as part of a  chimeric heavy chain that includes the 
membrane and external domains of the inactive YS:W  Ix 
(19).  To  examine the relative activities of Iga and Ig13 in 
the induction of the pre-B cell transition, we compared the 
previously reported IgJ] chimera and a similar construct ex- 
pressing the cytoplasmic domain of Iga. Both of these chi- 
meric immunoglobulins were coinjected with the cognate 
light chain gene described above, and at least two indepen- 
dent integrants were tested for each of these new strains. In 
contrast to  the  parental YS:W-IgM  mutant  Igs,  expres- 
sion of either the YS: VV-IgM: Ig0t or the YS : VV-IgM: 
Igl3 chimeras in the RAG-1 -/-  background reconstituted 
the  pre-B  cell  compartment  (Fig.  3).  Bone  marrow  cells 
from  RAG-1 -/-  mice  and  the  YS:W-IgM-transgenic 
YS:VV 
YS:VV  YS:VV  IgM -Ig(3 
Transgene:  IgM  YS:VV IgM  IgM -Ig~  IgM-Igc~  Y:F 
Background:  ~  RAG-1 -/-  RAG-1 -/o  RAG-1 -/-  RAG-1 -/-  RAG-1 -1-  RAG-1 -/- 
T4  lg  I0  415  418  23,  S  51  lU  24 
OD43 
Figure 3.  B cell development 
in the bone marrow oftLAG-1  -/ 
-  H2  a/d  IgM-tramgenic  n'fice. 
Bone marrow cells from 6- to 8- 
wk-old  transgenic mice  were 
analyzed by staining with PE-h- 
beled  anti-B220  and  FITC- 
labeled  anti-CD43.  The  lym- 
phocyte  population  was  gated 
according  to  standard forward- 
and  side-scatter  values.  The 
numbers in each quadrant repre- 
sent  the  percentages of  gated 
lymphocytes. 
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whereas  the  number  of  CD43-B220 +  cells  in  YS:VV- 
IgM : Igor-  and  YS :W-IgM:  Ig]~  RAG-1-/--transgenic 
mice resembled that found in wild-type mice (Fig. 3). Sim- 
ilar numbers ofpre-B  ceils were found in both sets ofYS: 
VV-IgM:Igot-  and  YS:W-IgM:Ig~  RAG-1-/--trans - 
genic strains.  Further,  the activation of the pre-B cell tran- 
sition by Ig[3 in the  chimeric heavy plus light chain RAG- 
1 -/-  transgenic  mice  was  dependent  on  the  presence  of 
cytoplasmic tyrosine residues in Ig[3.  Additional  strains that 
carry  the  light  chain  and  a  chimeric  heavy  chain  with  a 
mutation  oftyrosine  536 in the cytoplasmic domain of lg[3 
resulted in an Ig that was no longer able to induce  the pre- 
B  cell transition  (Fig.  3, right). 
We conclude that the cytoplasmic domain of Iglx resem- 
bles that of Ig[3 in that it contains  sufficient information  to 
produce  the signal that induces the pre-B cell transition. 
Igol Induces Allelic Exclusion.  To examine the role of Iglx 
in  allelic  exclusion  and  to  compare  the  activities  of Igo~ 
with Ig[3, we crossed all of the Ig-transgenic mice described 
above into BALB/c  mice that were wild type for RAG-1. 
Bone  marrow DNA  samples were then  tested for VDJ re- 
combination  by PCR.  In agreement with  previously pub- 
lished  experiments,  we  found  that  a  wild-type  membrane 
IgM transgene  was active in  allelic  exclusion,  inhibiting  V 
to DJ  rearrangements  but  not  D  to J  rearrangements  (Fig. 
4). By contrast,  heavy chains bearing the YS:VV  mutation 
that  interferes  with  the  ability  of b~  to  pair  with  Igot-Ig[3 
had  no  effect  on  gene  rearrangements,  even  when  they 
were  assembled  with  the  appropriate  cognate  light  chain 
(Fig.  4). Addition  of the  cytoplasmic domain  of Igor to the 
inactive YS ￿9  VV Ig resulted in a chimera that inhibited V  to 
DJ  but  not  D  to J  recombination  (Fig.  4).  Side-by-side 
comparisons of the YS : VVqgM  : Igix- and YS : VV-IgM : 
Ig[3-expressing strains  showed  that  the  two  were  indistin- 
guishable  in  their  ability  to  inhibit  recombination.  More- 
over,  as  was  shown  for  strains  that  carry just  the  heavy 
chain  (19),  inhibition  of V  to  DJ  rearrangements  was  de- 
pendent  on  the  presence  of cytoplasmic  tyrosines  in  Ig[3 
(Fig.  4).  Mice  that  carry the  combination  of the YS:VV- 
IgM" Ig[3/Y-F  and  the  light  chain  were  unable  to  induce 
allelic exclusion  (Fig.  4, right lane). 
We conclude  that the cytoplasmic tail of Igix is sufficient 
to mediate inhibition of V  to DJ recombination,  and, there- 
fore,  with  respect to  allelic  exclusion,  the  roles  of the  Ig0t 
and Ig[3 cytoplasmic domains are functionally equivalent. 
Discussion 
The  B  cell  antigen  receptor  is  a  complex  structure  that 
has a number of diverse regulatory functions in both devel- 
oping and mature B  cells. This receptor is composed of two 
disulfide-linked heterodimers that are noncovalently associ- 
ated on the plasma membrane (27-29).  The ligand-binding 
component, membrane IgM, has no signaling activity on its 
own but requires  Ig0~ and Ig[3 to activate cellular responses 
such as tyrosine phosphorylation  and Ca  2+ flux (15,  16,  18, 
30).  Although  the cytoplasmic domains  of Iger  and Ig13 are 
Figure  4.  Ig  gene rearrange- 
ments in transgenic mice assayed 
by PCR. Bone marrow samples 
were obtained from two individ- 
ual mice for each of the lines in- 
dicated. All mice were of a wild- 
type  (WT) genetic background 
that supports recombination, ex- 
cept for the indicated RAG-1 -/- 
control  sample.  Primer  se- 
quences  and  PCR  conditions 
were  as  previously described 
(25).  V558L, amplified DNA 
from  the  synonymous  V  gene 
family; DJ, amplified DNA from 
D  to  J  recombined  fragments; 
IVS, amplified DNA from inter- 
vening sequences. 
very different, both have a tyrosine-based SH2 target motif 
that is essential for signal transduction  (15,  16,  30).  As first 
pointed out by Reth  (31),  the YxxLxxxxxxxYxxL motif is 
also  found  in  a  number  of other  antigen  receptor-associ- 
ated proteins, including  CD3 components and FcR~.  In all 
cases studied  to date,  signal transduction  by this class  of re- 
ceptors  requires  cross-linking  (32)  and  is  believed  to  in- 
volve activation  of src  family kinases.  A  second  amplifica- 
tion  step  involves  binding  to  syk  family  kinases  (33),  for 
which  both  Igci  and  Ig~  have  similar  affinities  (34,  35). 
However,  the  cytoplasmic  domains  of Ig0~ and  Ig[3  have 
been shown to bind to different sets ofsrc kinases (14), and 
they  appear  to  have  different  signaling  functions  in  trans- 
fected cell lines  (15-17).  Given the diversity of cellular re- 
sponses activated by membrane  IgM,  it has been proposed 
that  individual  receptor  subunits  may  have  independent 
physiologic functions. 
We  have  sought  to  resolve  this  issue  by  measuring  the 
physiologic  activities  of Igor  and  Ig~  during  the  antigen- 
independent  phase of B  cell development.  For this purpose 
we produced transgenic mice that express chimeric Ig mol- 
ecules  composed  of the  extracellular  and  transmembrane 
domains of a YS : VV mutant heavy chain and the cytoplas- 
mic domains  of Igor and Ig13. Light chains were  coinjected 
with the Igor and IgI3 heavy chain transgenes to ensure  the 
assembly of a membrane-bound  receptor that could be ex- 
pressed  on  the  cell  surface  (Fig.  2,  bottom).  Previous  work 
has  shown  that  YS:VV  mutant  hea  W  chains  that  do  not 
contact  Igot-Ig[3 cannot  support  the  induction  of the  anti- 
gen-independent  phase  of B  cell  development  (19).  Fur- 
ther,  experiments with  chimeric  Igs showed that the cyto- 
plasmic  domain  of Ig[3  was sufficient  to  trigger the  pre-B 
cell transition  and allelic exclusion by a mechanism that re- 
quires phosphorylation  of the tyrosines  of its ARH1  motif 
(19). The addition of the light chain in the experiments we 
report here did not diminish the activity of either the wild- 
type  membrane-bound  tx  chain  or  the  YS :VV-IgM: Ig[3 
chimera in the induction  of the pre-B  cell transition  or al- 
lelic  exclusion  (Figs.  3  and  4).  Conversely,  the light  chain 
transgene  did  not  rescue  the  inactive  YS:VV-IgM  or  the 
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and 4).  Thus,  Ig heavy and light  chain assembly is neither 
required  for  nor  does  it  significantly  affect  the  antigen- 
independent  events in the B  cell pathway. 
Analysis of the  new  chimeric  molecules  with  the  cyto- 
plasmic tail of Igc~ showed that Igc~ is also sufficient to trig- 
ger the  pro- to pre-B  cell transition  (Fig.  3).  In addition, 
signaling through the Igci chimera can lead to inhibition  of 
recombination  at  endogenous  heavy  chain  loci  (Fig.  4). 
Thus, IgoL resembles Ig[3 in that its cytoplasmic domain can 
trigger both  of these antigen-independent  events.  Our re- 
suits are similar to recent reports that examine this question 
in  the  context  of the  TCR  (36,  37).  The  TCR  is  more 
complex than the B  cell receptor in that it is composed of 
two  independent  signaling  modules  (38-41)  (the  %  B, 
module  and  the  ~  dimer).  Experiments  with  CD3~ -/- 
mice  reconstituted  with  mutant  transgenic  ~  chains  have 
shown that ~ is required for assembly of the TCR,  but the 
signaling function  of ~ is not required  for T  cell  develop- 
ment (36).  In these mice, the %  8, ~ module was sufficient 
to  produce  CD4+CD8 -  and  CD4-CD8 +  T  cells  in  the 
complete absence of ~ signaling motifs (36).  Similarly, chi- 
meric molecules  composed of the  external and transmem- 
brane  domains  of the  IL-2  receptor  and  the  cytoplasmic 
domains  of the  CD3e  or  CD3~  tails  have  shown  that  in 
vivo  cross-linking  of either  one  was  sufficient  to  mediate 
the transition from the double-negative to the double-pos- 
itive  cell  stage  (37).  Thus,  in  developing  T  cells,  as  in  B 
cells,  the  physiologic  activity  of the  antigen  receptor  ho- 
mology  1-containing  signaling  proteins  is redundant,  and 
the presence of many molecules  containing  antigen recep- 
tor homology 1 motifs may simply function to amplify the 
signal. Nevertheless, these conclusions do not invalidate the 
suggestion that different signals might be delivered through 
the individual receptor-associated molecules, since only the 
early segments of the B  and T  cell pathways have been ex- 
amined.  There is, of course,  a possibility that IgoL and  Ig[3 
have different functions  in very early pro-B  cells.  Both  of 
these  proteins  are  expressed  before  VDJ  recombination 
(42-44),  and it has been suggested that they interact with a 
surrogate  heavy chain  to  form a  pro-B  cell receptor  (45). 
This receptor is thought to mediate activation of the transi- 
tion from the very early pro-B cell to the later stages in de- 
velopment.  It is also possible that events regulated by Ig in 
more mature B  cells, such as deletion  of autoreactive cells, 
silencing,  or  cellular  activation,  require  orchestration  of 
several signals,  thus  demanding  different  roles for IgoL and 
Ig~. In our transgenic mice, the heavy and light chain pair 
produces an anti-H2 k/k antibody, which results in the dele- 
tion ofautoreactive B cells in the appropriate genetic back- 
ground  (9).  Therefore,  the system we have developed will 
allow  us  to  test  for  differences  between  Igo~ and  Ig~3 at 
stages subsequent  to  those  of pre-B  cell  transition  and  al- 
lelic exclusion. 
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